Validation of the thrombin generation assay in pregnancy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON24748

Enrollment

120

Registered

2014-09-11

Start date

2014-09-17

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Women in the last trimester of their pregnancy.

Interventions

No intervention planned. This study is observational.

Eligibility

Inclusion criteria

Inclusion criteria: All healthy, adult women who are in the final trimester of their pregnancy.

Exclusion criteria

Exclusion criteria: Acquired and inherited coagulation abnormalities. HELLP-syndrome and pre-eclampsia.

Design outcomes

Primary

Measure	Time frame
Primary outcome is a reference range for a plasma thrombin generation assay and a newly developed whole blood thrombin generation assay.	—

Secondary

Measure	Time frame
Correlation with peri-partal bleeding.	—

Contacts

Public ContactM.D. Lancé

dept of anesthesiology MUMC+ P.Debeyelaan 25

marcus.lance@mumc.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)